ELBIO — Elviemek SA Income Statement
0.000.00%
Last trade - 00:00
FinancialsMicro Cap
2014 December 31st | 2015 December 31st | R2016 December 31st | 2017 December 31st | 2018 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.859 | 0.718 | 0.001 | 0.002 | 0.002 |
Cost of Revenue | |||||
Gross Profit | 0.46 | 0.42 | 0.001 | 0.002 | 0.002 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1.09 | 0.591 | 0.381 | 0.325 | 0.456 |
Operating Profit | -0.234 | 0.127 | -0.38 | -0.323 | -0.454 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -0.473 | -0.103 | -0.466 | -0.375 | -0.844 |
Provision for Income Taxes | |||||
Net Income After Taxes | -0.473 | -0.103 | -0.466 | -0.375 | -0.844 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -0.473 | -0.103 | -0.128 | 0.033 | -0.657 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -0.473 | -0.103 | -0.128 | 0.033 | -0.657 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.067 | -0.015 | -0.066 | -0.053 | -0.119 |
Dividends per Share |